BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22266802)

  • 1. Synergistic cytotoxic effect of sulindac and pyrrolidine dithiocarbamate against ovarian cancer cells.
    Jakubowska-Mućka A; Sieńko J; Zapała Ł; Wolny R; Lasek W
    Oncol Rep; 2012 Apr; 27(4):1245-50. PubMed ID: 22266802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of NF-kappaB inhibitor on cisplatin-induced apoptosis in cervical cancer].
    Xie LX; Hu LN; Chen HX; Peng X; Li JK
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Jan; 44(1):36-41. PubMed ID: 23600205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy.
    Zerbini LF; Tamura RE; Correa RG; Czibere A; Cordeiro J; Bhasin M; Simabuco FM; Wang Y; Gu X; Li L; Sarkar D; Zhou JR; Fisher PB; Libermann TA
    PLoS One; 2011; 6(9):e24285. PubMed ID: 21931671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of NF-κB by Pyrrolidine Dithiocarbamate Prevents the Inflammatory Response in a Ligature-Induced Peri-Implantitis Model: A Canine Study.
    He CY; Jiang LP; Wang CY; Zhang Y
    Cell Physiol Biochem; 2018; 49(2):610-625. PubMed ID: 30165363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines.
    Morais C; Pat B; Gobe G; Johnson DW; Healy H
    Nephrol Dial Transplant; 2006 Dec; 21(12):3377-88. PubMed ID: 16998220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic effects of pyrrolidine dithiocarbamate in small-cell lung cancer cells, alone and in combination with cisplatin.
    Tahata S; Yuan B; Kikuchi H; Takagi N; Hirano T; Toyoda H
    Int J Oncol; 2014 Oct; 45(4):1749-59. PubMed ID: 25070243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of Epigallocatechin gallate on ovarian cancer cell proliferation associated with aquaporin 5 expression.
    Yan C; Yang J; Shen L; Chen X
    Arch Gynecol Obstet; 2012 Feb; 285(2):459-67. PubMed ID: 21698451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells.
    Yip-Schneider MT; Nakshatri H; Sweeney CJ; Marshall MS; Wiebke EA; Schmidt CM
    Mol Cancer Ther; 2005 Apr; 4(4):587-94. PubMed ID: 15827332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of combined use of PDTC and paclitaxel on proliferation and invasion of human breast cancer cell line MCF-7].
    Yang C; Zhang H; Huang W; Lin Q; Wei H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Oct; 27(5):1105-9. PubMed ID: 21089680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.
    Piazza GA; Rahm AK; Finn TS; Fryer BH; Li H; Stoumen AL; Pamukcu R; Ahnen DJ
    Cancer Res; 1997 Jun; 57(12):2452-9. PubMed ID: 9192825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of nuclear factor-kappaB by an antioxidant enhances paclitaxel sensitivity in ovarian carcinoma cell line.
    Liu GH; Wang SR; Wang B; Kong BH
    Int J Gynecol Cancer; 2006; 16(5):1777-82. PubMed ID: 17009971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of NF-kappaB activation in the apoptosis induced by extracellular adenosine in human hepatocellular carcinoma HepG2 cells.
    Wu LF; Li GP; Su JD; Pu ZJ; Feng JL; Ye YQ; Wei BL
    Biochem Cell Biol; 2010 Aug; 88(4):705-14. PubMed ID: 20651843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xiaoaiping combined with cisplatin can inhibit proliferation and invasion and induce cell cycle arrest and apoptosis in human ovarian cancer cell lines.
    Zheng AW; Chen YQ; Fang J; Zhang YL; Jia DD
    Biomed Pharmacother; 2017 May; 89():1172-1177. PubMed ID: 28320083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The conventional nonsteroidal anti-inflammatory drug sulindac sulfide arrests ovarian cancer cell growth via the expression of NAG-1/MIC-1/GDF-15.
    Kim JS; Baek SJ; Sali T; Eling TE
    Mol Cancer Ther; 2005 Mar; 4(3):487-93. PubMed ID: 15767558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bithionol inhibits ovarian cancer cell growth in vitro - studies on mechanism(s) of action.
    Ayyagari VN; Brard L
    BMC Cancer; 2014 Feb; 14():61. PubMed ID: 24495391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of nuclear factor kappa B transcription activity drives a synergistic effect of pyrrolidine dithiocarbamate and cisplatin for treatment of renal cell carcinoma.
    Morais C; Gobe G; Johnson DW; Healy H
    Apoptosis; 2010 Apr; 15(4):412-25. PubMed ID: 19856104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of pyrrolidine dithiocarbamate and cisplatin in human cervical carcinoma.
    Zheng X; Lv J; Shen Q; Chen Y; Zhou Q; Zhang W; Zhu X
    Reprod Sci; 2014 Oct; 21(10):1319-25. PubMed ID: 24594834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulindac activates NF-κB signaling in colon cancer cells.
    Mladenova D; Pangon L; Currey N; Ng I; Musgrove EA; Grey ST; Kohonen-Corish MR
    Cell Commun Signal; 2013 Oct; 11():73. PubMed ID: 24083678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrrolidine dithiocarbamate-induced apoptosis depends on cell type, density, and the presence of Cu(2+) and Zn(2+).
    Erl W; Weber C; Hansson GK
    Am J Physiol Cell Physiol; 2000 Jun; 278(6):C1116-25. PubMed ID: 10837339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal bovine serum requirement for pyrrolidine dithiocarbamate-induced apoptotic cell death of MCF-7 breast tumor cells.
    Oh DH; Bang JS; Choi HM; Yang HI; Yoo MC; Kim KS
    Eur J Pharmacol; 2010 Dec; 649(1-3):135-9. PubMed ID: 20868670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.